Actelion's CEO Said to Reject Full Takeover by Johnson & Johnson (JNJ), May Sell Unit - Source

November 30, 2016 11:14 AM EST Send to a Friend
Despite an offer from Johnson & Johnson (NYSE: JNJ), Actelion's (OTC: ALIOY) CEO Jean-Paul Clozel has decided that the company ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login